haloperidol decanoate has been researched along with 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dysken, MW; Holden, L; Johnson, SB; Kim, SW; Skare, S; Thomsyck, L; Vatassery, G | 1 |
Cahard, C; Conquy, T; Rop, PP; Viala, A | 1 |
Chang, WH; Chen, LC; Chien, CP; Hu, WH; Jann, MW; Juang, DJ; Lam, YF; Lin, SK; Yang, CH | 1 |
Chang, WH; Chen, LC; Chien, CP; Hu, WH; Jann, MW; Juang, DJ; Lam, YW; Lin, SK; Yang, CH | 1 |
Belpaire, FM; Berlo, JA; De Schepper, N; Pan, L; Rosseel, MT; Vander Stichele, R | 1 |
5 other study(ies) available for haloperidol decanoate and 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol
Article | Year |
---|---|
Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
Topics: Adult; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Erythrocytes; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Psychiatric Status Rating Scales; Psychotic Disorders | 1992 |
High-performance liquid chromatographic analysis of haloperidol and hydroxyhaloperidol in plasma after solid-phase extraction.
Topics: Chromatography, High Pressure Liquid; Haloperidol; Humans; Quality Control | 1990 |
Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Female; Haloperidol; Humans; Male; Middle Aged; Regression Analysis; Schizophrenia | 1993 |
Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawal.
Topics: Adult; Female; Half-Life; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1993 |
Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
Topics: Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Enzyme Induction; Enzyme Inhibitors; Genotype; Haloperidol; Humans; Inpatients; Middle Aged; Polymorphism, Genetic; Polypharmacy; Schizophrenia; Smoking | 1999 |